Monthly Archives: July 2010

They said it couldn’t be done. No less a genius than Leonardo da Vinci tried to design a workable airplane. He got as far as building a couple of gliders and apparently even soared off the roof of a barn … Continue reading →

Results from a new study suggest that oral contraceptives and hormone replacement therapy (HRT) may yield additional benefit of protecting against the formation and rupture of brain aneurysms in women. The findings from this first-of-its-kind study by a neurointerventional expert … Continue reading →

Nature Reviews Clinical Oncology 7, 422 (2010). doi:10.1038/nrclinonc.2010.109 Author: Lisa Hutchinson The antitumor efficacy of oncolytic viruses can be influenced by the immune system. Adenoviruses are among the most advanced cancer gene therapy approaches; however, despite evidence of activity of … Continue reading →

Mucopolysaccharidosis (MPS) IVA is an autosomal recessive disorder caused by deficiency of the lysosomal enzyme N-acetylgalatosamine-6-sulfate sulfatase (GALNS), which leads to the accumulation of keratan sulfate and chondroitin 6-sulfate, mainly in bone. To explore the possibility of gene therapy for … Continue reading →

Authors: W-B Pyun, W Hahn, D-S Kim, W-S Yoo, S-D Lee, J-H Won, B-S Rho, Z-Y Park, J-M Kim & S Kim (Source: Gene Therapy)

Authors: G-J Ye, M M Scotti, J Liu, L Wang, D R Knop & G Veres (Source: Gene Therapy)

Authors: S Peng, A Monie, T H Kang, C-F Hung, R Roden & T-C Wu (Source: Gene Therapy)

Authors: S R Riddell & U Protzer (Source: Gene Therapy) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Winners and losers and oncolytic adenoviruses: who should be down in the mouth? Gene Therapy advance online publication, July 29, 2010. doi:10.1038/gt.2010.98 Author: K J Harrington (Source: Gene Therapy)